Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.3521
0.00 (0.00%)
At close: May 14, 2026

RVPH Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
533841448740
Market Cap Growth
-89.00%-61.33%-41.36%65.49%115.01%-49.95%
Enterprise Value
-101979139647
Last Close Price
0.355.5836.20103.0085.0057.80
PB Ratio
0.263.77103.7625.1410.351.41
P/TBV Ratio
0.263.77103.7625.1410.351.41
Debt / Equity Ratio
0.010.050.56---
Net Debt / Equity Ratio
-1.26-1.62-16.02-4.09-2.21-1.03
Net Debt / EBITDA Ratio
-----2.94
Quick Ratio
3.631.990.921.361.8612.66
Current Ratio
3.852.081.011.381.9013.39
Return on Equity (ROE)
-256.20%-419.97%-916.17%-556.38%-152.43%-49.91%
Return on Assets (ROA)
-69.09%-80.35%-98.20%-115.85%-70.11%-31.45%
Return on Capital Employed (ROCE)
-97.10%-233.60%-3416.10%-605.40%-315.00%-34.80%
Earnings Yield
-368.65%-60.93%-35.49%-27.31%-32.53%-21.09%
Buyback Yield / Dilution
-147.07%-114.96%-41.84%-21.94%-31.95%-383.10%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.